To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

Clinical trial NCT04551066 · TERMINATED

Trial details

NCT number: NCT04551066
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelofibrosis Primary Myelofibrosis Post Essential Thrombocythemia Myelofibrosis Post Polycythemia Vera Myelofibrosis

Start date: 2021-05-24
Primary completion: 2023-08-03
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.